Cell Medica will present interim data from the ongoing CITADEL clinical trial of CMD-003 in patients with NKT lymphoma at the prestigious American Society of Hematology conference in Atlanta on Monday, December 11, 2017, 6:00 PM-8:00 PM please click here to see full details https://ash.confex.com/ash/2017/webprogram/Paper101920.html